ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 183 filers reported holding ALKERMES PLC in Q3 2020. The put-call ratio across all filers is 9.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,108,190 | +1.7% | 967,804 | +13.7% | 0.02% | 0.0% |
| Q2 2023 | $26,646,629 | +19.5% | 851,330 | +7.7% | 0.02% | +15.0% |
| Q1 2023 | $22,289,833 | +68.8% | 790,700 | +56.5% | 0.02% | +81.8% |
| Q4 2022 | $13,202,862 | +51.7% | 505,276 | +29.6% | 0.01% | +37.5% |
| Q3 2022 | $8,703,000 | -5.7% | 389,728 | +25.8% | 0.01% | -11.1% |
| Q2 2022 | $9,227,000 | +14.2% | 309,743 | +0.9% | 0.01% | +50.0% |
| Q1 2022 | $8,077,000 | +13.9% | 307,008 | +0.7% | 0.01% | +20.0% |
| Q4 2021 | $7,094,000 | -8.7% | 304,982 | +21.0% | 0.01% | -16.7% |
| Q3 2021 | $7,772,000 | +17.3% | 252,015 | -28.9% | 0.01% | +20.0% |
| Q1 2021 | $6,624,000 | -19.2% | 354,615 | -13.7% | 0.01% | -16.7% |
| Q4 2020 | $8,197,000 | +35.6% | 410,866 | +12.6% | 0.01% | +20.0% |
| Q3 2020 | $6,046,000 | -11.3% | 364,878 | +3.9% | 0.01% | -28.6% |
| Q2 2020 | $6,817,000 | +34.2% | 351,290 | -0.2% | 0.01% | +16.7% |
| Q1 2020 | $5,078,000 | -32.7% | 352,127 | -4.8% | 0.01% | -14.3% |
| Q4 2019 | $7,547,000 | +13.4% | 369,927 | +8.4% | 0.01% | 0.0% |
| Q3 2019 | $6,656,000 | +46.1% | 341,171 | +68.8% | 0.01% | +40.0% |
| Q2 2019 | $4,555,000 | -43.2% | 202,100 | -8.0% | 0.01% | -50.0% |
| Q1 2019 | $8,018,000 | +15.7% | 219,745 | -6.4% | 0.01% | 0.0% |
| Q4 2018 | $6,928,000 | -35.7% | 234,781 | -7.5% | 0.01% | -28.6% |
| Q3 2018 | $10,775,000 | -9.8% | 253,893 | -12.6% | 0.01% | -17.6% |
| Q2 2018 | $11,950,000 | -41.8% | 290,341 | -18.0% | 0.02% | -41.4% |
| Q1 2018 | $20,531,000 | +0.5% | 354,222 | -5.1% | 0.03% | +3.6% |
| Q4 2017 | $20,422,000 | +71.4% | 373,146 | +59.3% | 0.03% | +55.6% |
| Q3 2017 | $11,912,000 | -10.6% | 234,300 | +2.0% | 0.02% | -14.3% |
| Q2 2017 | $13,322,000 | +1.3% | 229,800 | +2.2% | 0.02% | 0.0% |
| Q1 2017 | $13,151,000 | +0.9% | 224,800 | -4.1% | 0.02% | -4.5% |
| Q4 2016 | $13,034,000 | +18.2% | 234,500 | 0.0% | 0.02% | +22.2% |
| Q3 2016 | $11,029,000 | -3.0% | 234,500 | -10.9% | 0.02% | 0.0% |
| Q2 2016 | $11,371,000 | +22.8% | 263,100 | -2.9% | 0.02% | +20.0% |
| Q1 2016 | $9,262,000 | -60.1% | 270,900 | -7.4% | 0.02% | -59.5% |
| Q4 2015 | $23,235,000 | +36.7% | 292,700 | +1.0% | 0.04% | +27.6% |
| Q3 2015 | $16,997,000 | -7.8% | 289,700 | +1.2% | 0.03% | +3.6% |
| Q2 2015 | $18,427,000 | -7.2% | 286,400 | +1.8% | 0.03% | +3.7% |
| Q1 2015 | $19,855,000 | 0.0% | 281,433 | 0.0% | 0.03% | 0.0% |
| Q4 2014 | $19,855,000 | +63.4% | 281,433 | -0.7% | 0.03% | +58.8% |
| Q3 2014 | $12,154,000 | -19.4% | 283,502 | -5.4% | 0.02% | -19.0% |
| Q2 2014 | $15,084,000 | +19.8% | 299,709 | +0.2% | 0.02% | +16.7% |
| Q1 2014 | $12,589,000 | +13.1% | 299,169 | +10.5% | 0.02% | +12.5% |
| Q4 2013 | $11,129,000 | +31.6% | 270,849 | +7.7% | 0.02% | 0.0% |
| Q3 2013 | $8,455,000 | +9.1% | 251,494 | -6.9% | 0.02% | 0.0% |
| Q2 2013 | $7,750,000 | – | 270,206 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |